STERIS SG&A increased by 0.7% to $352.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $335.50M to $352.30M. Over 3 years (FY 2022 to FY 2025), SG&A shows relatively stable performance with a 0.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
selling_general_and_administrativeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $393.75M | $344.80M | $310.56M | $269.37M | $334.63M | $323.20M | $305.14M | $127.70M | $306.53M | $328.43M | $308.30M | $309.06M | $335.60M | $329.30M | $335.50M | $333.88M | $353.80M | $349.70M | $352.30M |
| QoQ Change | — | -12.4% | -9.9% | -13.3% | +24.2% | -3.4% | -5.6% | -58.2% | +140.0% | +7.1% | -6.1% | +0.2% | +8.6% | -1.9% | +1.9% | -0.5% | +6.0% | -1.2% | +0.7% |
| YoY Change | — | — | — | — | -15.0% | -6.3% | -1.7% | -52.6% | -8.4% | +1.6% | +1.0% | +142.0% | +9.5% | +0.3% | +8.8% | +8.0% | +5.4% | +6.2% | +5.0% |
Business Segments
| Segment | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Life Sciences: | — | — | — | — | — | — | $16.10M | $15.60M |
| Life Science Member | $14.55M | $14.55M | $14.55M | $14.55M | $14.80M | $16.00M | — | — |
| Total | $306.53M | $328.43M | $308.30M | $309.06M | $335.60M | $353.80M | $349.70M | $352.30M |
Life Science Member was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
SG&A at Other Companies
Frequently Asked Questions
- What is STERIS's sg&a?
- STERIS (STE) reported sg&a of $352.30M in Q4 2025.
- How has STERIS's sg&a changed year-over-year?
- STERIS's sg&a increased by 5.0% year-over-year, from $335.50M to $352.30M.
- What is the long-term trend for STERIS's sg&a?
- Over 3 years (2022 to 2025), STERIS's sg&a has grown at a 0.4% compound annual growth rate (CAGR), from $1.32B to $1.33B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.